Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.
Kanda Y, Kimura SI, Iino M, Fukuda T, Sakaida E, Oyake T, Yamaguchi H, Fujiwara SI, Jo Y, Okamoto A, Fujita H, Takamatsu Y, Saburi Y, Matsumura I, Yamanouchi J, Shiratori S, Gotoh M, Nakamura S, Tamura K; Japan Febrile Neutropenia Study Group. Kanda Y, et al. Among authors: oyake t. J Clin Oncol. 2020 Mar 10;38(8):815-822. doi: 10.1200/JCO.19.01916. Epub 2020 Jan 24. J Clin Oncol. 2020. PMID: 31977270 Clinical Trial.
Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial.
Kimura SI, Kanda Y, Iino M, Fukuda T, Sakaida E, Oyake T, Yamaguchi H, Fujiwara SI, Jo Y, Okamoto A, Fujita H, Takamatsu Y, Saburi Y, Matsumura I, Yamanouchi J, Shiratori S, Gotoh M, Nakamura S, Tamura K; Japan Febrile Neutropenia Study Group. Kimura SI, et al. Among authors: oyake t. Int J Infect Dis. 2020 Nov;100:292-297. doi: 10.1016/j.ijid.2020.08.081. Epub 2020 Sep 3. Int J Infect Dis. 2020. PMID: 32891738 Free article. Clinical Trial.
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine.
Shimazu Y, Mizuno S, Fuchida SI, Suzuki K, Tsukada N, Hanagaishi A, Itagaki M, Kataoka K, Kako S, Sakaida E, Yoshioka S, Iida S, Doki N, Oyake T, Ichinohe T, Kanda Y, Astuta Y, Takamatsu H; working group of the Japan Society for Transplantation, Cellular Therapy. Shimazu Y, et al. Among authors: oyake t. Cancer Sci. 2021 Dec;112(12):5034-5045. doi: 10.1111/cas.15163. Epub 2021 Oct 26. Cancer Sci. 2021. PMID: 34644446 Free PMC article.
Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry.
Koresawa-Shimizu R, Suzuki R, Uehara Y, Hiramoto N, Sawa M, Fukuda T, Kataoka K, Kanda Y, Oyake T, Kubota Y, Uchida N, Yano S, Kobayashi H, Tanaka J, Atsuta Y, Kondo E. Koresawa-Shimizu R, et al. Among authors: oyake t. Bone Marrow Transplant. 2024 Jan;59(1):125-127. doi: 10.1038/s41409-023-02118-w. Epub 2023 Oct 7. Bone Marrow Transplant. 2024. PMID: 37805626 No abstract available.
Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation.
Hotta M, Satake A, Yoshimura H, Fujita S, Katayama Y, Ota S, Hanamoto H, Oyake T, Ito S, Okada M, Nakanishi T, Ito T, Ishii K, Nomura S. Hotta M, et al. Among authors: oyake t. Transplant Cell Ther. 2021 Aug;27(8):660.e1-660.e8. doi: 10.1016/j.jtct.2021.04.025. Epub 2021 May 12. Transplant Cell Ther. 2021. PMID: 33989832 Free article.
Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.
Yakushijin K, Ikezoe T, Ohwada C, Kudo K, Okamura H, Goto H, Yabe H, Yasumoto A, Kuwabara H, Fujii S, Kagawa K, Ogata M, Onishi Y, Kohno A, Watamoto K, Uoshima N, Nakamura D, Ota S, Ueda Y, Oyake T, Koike K, Mizuno I, Iida H, Katayama Y, Ago H, Kato K, Okamura A, Kikuta A, Fukuda T. Yakushijin K, et al. Among authors: oyake t. Bone Marrow Transplant. 2019 May;54(5):674-680. doi: 10.1038/s41409-018-0304-4. Epub 2018 Aug 20. Bone Marrow Transplant. 2019. PMID: 30127466 Clinical Trial.
Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.
Yamasaki S, Chihara D, Kim SW, Kawata T, Mizuta S, Ago H, Chou T, Yamane T, Uchiyama H, Oyake T, Miura K, Saito B, Taji H, Nakamae H, Miyamoto T, Fukuda T, Kanda J, Atsuta Y, Suzuki R. Yamasaki S, et al. Among authors: oyake t. Int J Hematol. 2019 Feb;109(2):175-186. doi: 10.1007/s12185-018-2560-x. Epub 2018 Nov 14. Int J Hematol. 2019. PMID: 30430419
42 results